Patent and Utility Patent Law


CMS Germany has an effective and experienced team of patent and utility patent specialists. Where issues are particularly complex, we work closely with our clients' own experts and with external patent attorneys.

If all else fails, we represent you in court

Our lawyers advise and represent you in infringement cases. We have extensive experience both on the claimant's and on the defendant's side. In other words, CMS has the right strategy for you in any situation.

During preparations for patent infringement lawsuits we provide support by conducting inspections and other preservation of evidence procedures. We also advise you on nullity, opposition and cancellation proceedings.

In urgent cases we can obtain temporary injunctions on your behalf. We also take criminal and civil action against patent infringements. CMS is also the right partner for you in border seizure proceedings.

We can help prevent court cases

In addition to in-court representation, our experts can also provide out-of-court services on your behalf. Examples include:

CMS Germany's lawyers provide ongoing strategic advice on property rights, including employee inventions.

We advise on exploiting your inventions

We advise on, design and negotiate licensing, research and development and cooperation agreements to ensure the best possible protection for your interests.

What others say about us

"A frequently recommended law firm for patent law."
 (JUVE Handbook)

Read more Read less


Show only
Dr. Thomas Meyding
Jason In­dus­tries, Inc., grows in Europe with ad­vice...
European Pat­ent Of­fice 2018 An­nu­al Re­port
The European Pat­ent Of­fice (EPO) 2018 An­nu­al Re­port was pub­lished this month show­ing cur­rent trends in the use of the sys­tem, as well as how the sys­tem is per­form­ing against qual­ity con­trol mark­ers. The US con­tin­ues to be the greatest user of the sys­tem in.
March 2014
Up­date Gew­erb­lich­er Rechtss­chutz und Kar­tellrecht 03/14...
Judg­ment on Ab­rax­is C-443/17; 21st March 2019
The CJEU de­livered its judg­ment last week on the case of Ab­rax­is v Comp­troller Gen­er­al of Pat­ents con­cern­ing Sup­ple­ment­ary Pro­tec­tion Cer­ti­fic­ates (SPCs) for new for­mu­la­tions of medi­cin­al products. The Court has ruled that Art­icle 3(d) of Reg­u­la­tion No 469/2009,.
Mai 2013
Up­date Gew­erb­lich­er Rechtss­chutz und Kar­tellrecht 05/13...